News & Events


News & Events

Latest News

30 March 2016Immunocore’s IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma

21 March 2016

3rd Immunotherapy of Cancer (ITOC-3)
21st - 23rd March 2016
Munich, Germany

15 March 2016

Immunosuppression Summit
15th - 17th March 2016
London, UK

14 March 2016

Cancer Biotherapeutics
March 14th - 16th 2016
London, UK

06 March 2016

Molecular Med Tri Conference
6th - 11th March 2016
San Francisco, US

06 March 2016

Keystone Symposia: Cancer Vaccines
6th - 10th March 2016
Whistler, Canada

25 February 2016

11th Annual Biomarkers Congress
25th - 26th February 2016
Manchester, UK

23 February 2016

Keystone Symposia: Immunity in Skin Development, Homeostasis and Disease
28th February - 2nd March 2016
California, US

01 February 2016

Biologics and Biosimilars Congress
1st - 2nd February 2016
Berlin, Germany

25 January 2016Immunocore’s IMCgp100 Granted Orphan Drug Designation by US FDA for the Treatment of Uveal Melanoma